The Children’s Cancer Center at Staten Island University Hospital provides diagnosis, treatment, and follow-up for infants, children, and adolescents from infancy to adulthood. The Center offers a comprehensive and collaborative approach to the diagnosis and treatment of pediatric cancer, following the guidelines of national pediatric cancer study groups. Children diagnosed with sickle cell disease at birth are also referred to the center for comprehensive evaluation and treatment.
The Center offers outpatient and inpatient care, including cancer chemotherapy, blood transfusions, factor infusions, gamma globulin infusions, and more:
- Pediatric Malignancies (including Leukemias, Lymphoid Malignancies and Solid Tumors)
- Comprehensive Services for Hemoglobinopathies (including Sickle Cell Disorders and Thalassemies)
- Disorders of Coagulation (including Thrombophilic Disorders, Hemophilias and Von Willebrand Disorders)
- Platelet Disorders (including Immue Thrombocytopenias and Platelet Dysfunction)
- Red Cell Disorders (including Anemias and Hemolytics Disorders)
- White Cell Disorders
- Evaluation for Lymphadenopathy and Fevers of Unknown Origin
- Hystiocytic Disorders
Pediatric Hematology-Oncology Faculty
Sarah R. Vaiselbuh, MD - Medical Director
Dr. Vaiselbuh received her Medical Degree from the University of Antwerp Belgium and completed her initial medical training in Belgium in Internal Medicine and Adult Bone Marrow Transplatation. She completed a second residency in Pediatrics at SUNY Downstate Medical Center, NY, and a fellowship in Pediatric Hematology-Oncology at Cohen Children's Medical Center, a member hospital of North Shore LIJ system. Dr. Vaiselbuh also received international training in the United Kingdom, Netherlands and Australia.
She specializes in histiocytic disorders, pediatric leukemia and lymphoma, and her research focuses on stem cell niche biology and the tumor microenvironment. She says that her intellectual battle of basic science helps her to overcome the emotional toll clinical oncology can take at times. Her patients' clinical presentation help her to design basic research questions, leading to transnational medicine, from bed to bench and vice versa. She is board-ceritifed in general pediatrics and pediatric hematology and oncology, and her dedication to her field has earned her numerous research rewards, most recently the Jon Pritchard Fellow Awad in Histiocytosis and the Edwin Marks Award for Excellence in Research at the Feinstein Institute.
Dr. Vaiselbuh is an active member of the American Society of Pediatric Hematology Oncology where she is the chair of the young investigator committee as well as the specialty interest group on diversity. As a member of the program committee at ASPHO, she has organized several symphosia and workshops at annual meetings. In addition, she holds memberships to the Histiocyte Society and the American Society of Hematology.
2010 - Edwin S. Marks Award for Excellence in Research
2011 - Jon Pritchard Fellow Award in Histiocytosis
2011 - Outstanding Professional of the Year Award in the field of Pediatric Hemato/Oncology - Cambridge Who's who?
2013 - Nomination for Sandra Atlan Bass Award for Clinical Excellen (recognizes accomplished women physicians in the health care system)
Eleny Romanos-Sirakis, MD
Dr. Romanos-Sirakis received her medical Degree from New York University School of Medicine. She completed her Pediatric Residency at New York University as well as her Pediatric Hematology/Oncology fellowship at New york University.
Dr. Romanos-Sirakis serves as the director of the hemoglobinopathy specialty center at SIUH, providing comprehensive care to patients with sickle cell disease. Dr. Romanos-Sirakis' expertise includes all pediatric blood disorders and oncologic diagnoes. She has a stong interest in researchand is actively involved in education at SIUH. She is a member of the Amerivan Society of Hematology and the American Society of Pediatric Hematology/Oncology. Dr. Romanos - Sirakis is dedicated to providing high-quality and personalised xare for all of her patients. She provides hematology and oncology evaluations and care for patients from birth to 21 yesrs of age.